 |
인쇄하기
취소
|
Combined hypertensive medicines market warming up
The domestic market of combined antihypertensive agents is gaining momentum with Korean leading manufacturers who see opportunities in the field.
Novartis Korea has pioneered the field with its Exforge in 2007 and garnered 17.7 billion won in last year’s sales.
Hanmi Pharm and Daewoong Pharm have jumped into the market expecting larger figures.
The Korea’s antihypertensive drug market ...
Novartis Korea has pioneered the field with its Exforge in 2007 and garnered 17.7 billion won in last year’s sales.
Hanmi Pharm and Daewoong Pharm have jumped into the market expecting larger figures.
The Korea’s antihypertensive drug market ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.